Show Menu

A fully integrated developer and manufacturer of ovine polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for August 2015

Investment in Research & Development

MicroPharm is pleased to announce that Flynn Pharma (Holdings) Ltd has acquired a majority shareholding in the Company.

Read the full story

Posted on: Friday, 14th August 2015